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Abstract The first order conditional estimation (FOCE)
method is still one of the parameter estimation workhorses
for nonlinear mixed effects (NLME) modeling used in
population pharmacokinetics and pharmacodynamics.
However, because this method involves two nested levels
of optimizations, with respect to the empirical Bayes esti-
mates and the population parameters, FOCE may be nu-
merically unstable and have long run times, issues which
are most apparent for models requiring numerical integra-
tion of differential equations. We propose an alternative
implementation of the FOCE method, and the related
FOCEI, for parameter estimation in NLME models. Instead
of obtaining the gradients needed for the two levels of
quasi-Newton optimizations from the standard finite dif-
ference approximation, gradients are computed using so
called sensitivity equations. The advantages of this ap-
proach were demonstrated using different versions of a
pharmacokinetic model defined by nonlinear differential
equations. We show that both the accuracy and precision of
gradients can be improved extensively, which will increase
the chances of a successfully converging parameter esti-
mation. We also show that the proposed approach can lead
to markedly reduced computational times. The
accumulated effect of the novel gradient computations
ranged from a 10-fold decrease in run times for the least
complex model when comparing to forward finite differ-
ences, to a substantial 100-fold decrease for the most
complex model when comparing to central finite differ-
ences. Considering the use of finite differences in for in-
stance NONMEM and Phoenix NLME, our results suggests
that significant improvements in the execution of FOCE are
possible and that the approach of sensitivity equations
should be carefully considered for both levels of
optimization.
Keywords Nonlinear mixed effects modeling  First
order conditional estimation (FOCE)  Sensitivity equations
Introduction
Nonlinear mixed effects (NLME) models are suitable
in situations where sparse time-series data is collected from
a population of individuals exhibiting inter-individual
variability [10]. This property has rendered NLME models
popular in both pharmacokinetics and pharmacodynamics,
and several public and commercial software packages have
been developed for performing NLME modeling within
these fields [13]. These modeling softwares include the
well-known NONMEM [5], which was the first program to
be developed and still is one of the most widely used, but
also a number of other programs such as Phoenix
NLME [21] and Monolix [15]. A core part of their func-
tionality consist of various methods for addressing the
problem of parameter estimation in NLME models, and
several studies have been devoted to describing and com-
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The ‘‘mixed effects’’ in NLME refers to the fact that these
models contain both fixed effect parameters, having the same
value for all individuals, and random effect parameters,
whose value differ from one individual to another and whose
distribution in the population is determined by some statis-
ticalmodel.A common approach to the parameter estimation
problem in NLME models is based on maximizing the so
called population likelihood. The population likelihood is a
function of the fixed effect parameters only, and it is obtained
by marginalizing out the random effects from the joint dis-
tribution of data and random effects. However, the integral
required for the marginalization lacks a closed-form solution
for all realistic problems. Because of this, maximum likeli-
hood parameter estimation for NLME models revolves
around different numerical approximation methods for
computing this integral. One of the main approaches for
tackling the problem is a class of related methods based on
the so called Laplacian approximation [25]. It includes the
popular and widely used first order conditional estimation
(FOCE)method, which is a special case of the closely related
FOCEwith interaction (FOCEI).With the FOCE and FOCEI
methods, the approximation of the integral involves a Taylor
expansion around the values of the random effect parameters
that maximize the joint distribution. This means that one
optimization problem per individual has to be solved for
every evaluation of the approximated population likelihood.
Since the aim is to maximize the (approximated) population
likelihood, which constitutes the original optimization
problem, conditional estimation methods such as FOCE
produce a parameter estimation problem involving two
nested layers of optimizations. For some NLME parameter
estimation problems this results in long execution times, and
in difficulties with numerical precision making the opti-
mizations unstable and limiting the precision of estimates
and the ability of obtaining confidence intervals. These is-
sues are particularly pronounced for models that are for-
mulated by systems of differential equations which are
lacking analytical solutions [4, 7, 8].
The optimization problems resulting from the FOCE and
FOCEI approximations, and other closely related ap-
proximations, are typically solved using gradient-based op-
timization methods such as the Broyden–Fletcher–Goldfarb–
Shanno (BFGS) quasi-Newton method [20]. For problems
where analytical expressions for the function and its gradient
are not available, it is common that gradients are computed by
finite difference approximations. We instead propose another
approach for determining the gradient of the FOCE and
FOCEI approximations of the population likelihood. Our
approach is based on formally differentiating the likelihoods
used at the two levels of optimization, and computing the
required derivatives of the model state variables using so
called sensitivity equations. The proposed approach for
computing gradients is readily applicable for the inner level of
the nested optimization problem. However, we also derive the
necessary theory for computing gradients through the ap-
proach of sensitivity equations at the outer level optimization.
This step is the more challenging, and requires that sensi-
tivities up to second order of the state variables with respect to
the parameters and random parameters are obtained. Being
able to compute the gradient of the FOCE or FOCEI ap-
proximations of the population likelihood using the approach
introduced in this paper is a great advantage as it circumvents
the need for repeatedly having to solve the inner level opti-
mization problem for obtaining the outer level gradients from
a finite difference approximation.
This paper is organized in the following way. First, the
mathematical theory is introduced. Here we recapitulate
NLMEmodels based on differential equations, including the
formulation of the population likelihood and its ap-
proximations, as well as derive expressions for both the
gradients of the individual joint log-likelihoods with respect
to the random effect parameters, used for the inner level
optimization problems, and the gradient of the approximate
population likelihood with respect to the fixed effect pa-
rameters, used for the outer level optimization problem.
Then, we apply the sensitivity approach for computing the
gradients for different versions of a benchmark model.
Compared to the finite difference approximation, the pro-
posed approach leads to both higher precision and better
accuracy of the gradient, as well as decreased computational
times. Finally, the presented results are discussed and pos-
sible future extensions are outlined.
Theory
Various definitions and results from matrix calculus are
used in the derivations of this section. These can be found
in the ‘‘Appendix 1’’ section.
The nonlinear mixed effects model
Consider a population of N subjects and let the ith indi-
vidual be described by the dynamical system
dxiðtÞ
dt








where xiðtÞ is a set of state variables, which for instance
could be used to describe a drug concentration in one or
more compartments, and where ZiðtÞ is a set of possibly
time dependent covariates, h a set of fixed effects pa-
rameters, and gi a set of random effect parameters which
are multivariate normally distributed with zero mean and
covariance X. The covariance matrix X is in general un-
known and will therefore typically contain parameters
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subject to estimation. These parameters will for conve-
nience of notation be included in the fixed effect parameter
vector h. Fixed effects parameters will hence be used to
refer to all parameters that are not random, not being
limited for parameters appearing in the model differential
equations. A model for the jth observation of the ith indi-
vidual at time tji is defined by
yij ¼ h








xij; tji ;ZiðtjiÞ; h; gi

; ð3Þ
and where the index notation ij is used as a short form for
denoting the ith individual at the jth observation. Note that
any fixed effect parameters of the observational model are
included in h. Furthermore, we let the expected value of the







Given a set of experimental observations, dij, for the in-
dividuals i ¼ 1; . . .;N at the time points tji , where
j ¼ 1; . . .; ni, we define the residuals
ij ¼ dij  y^ij; ð5Þ
















































and where di is used to denote the collection of data from
all time points for the ith individual.
The FOCE and FOCEI approximations
The marginalization with respect to gi in Eq. 6 does not






where the individual joint log-likelihoods are






















a closed form solution can be obtained by approximating
the function li with a second order Taylor expansion with
respect to gi. This is the well-known Laplacian ap-
proximation. Furthermore, we let the point around which
the Taylor expansion is done to be conditioned on the gi
maximizing li, here denoted by g

i ; I.e., the expansion is
done at the mode of the posterior distribution. Thus, the
approximate population likelihood, LL, becomes
















Here, the Hessian Dliðgi Þ is obtained by first differentiating
li twice with respect to gi, and evaluating at g

i . If we let gik



























Differentiating component-wise again, now with respect to






























































where the last term is really just the klth element of X1,
X1kl . The expression for the elements of the Hessian may
be approximated in different ways, with the main purpose
of avoiding the need for computing the costly second order
derivatives. We apply a first order approximation, where
terms containing second order derivatives are ignored, and
write the elements of the approximate Hessian, Hi, as
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This variant of the Laplacian approximation of the popula-
tion likelihood is known as the first order conditional esti-
mation with interaction (FOCEI) method. The closely related
first order conditional estimation (FOCE) method is obtained
by ignoring the dependence of the residual covariance matrix
on the random effect parameters. The rationale for excluding
the second order terms is that their expected values are zero
for an appropriate model, as shown in the ‘‘Appendix 2’’
section. The Appendix also shows how the Hessian may be
slightly further simplified, using similar arguments, to arrive
at the variant of FOCE used in NONMEM. Those additional
simplifications are however of relatively little importance
from a computational point of view, since the components
needed to evaluate these Hessian terms have to be provided
for the remaining part of the Hessian anyway. We will
therefore restrict the Hessian simplification by expectation to
the second order terms only. Furthermore, we will from now
on for convenience consider the logarithm of the FOCEI
approximation to the population likelihood, LF ,













Gradient of the individual joint log-likelihood
with respect to the random effect parameters
We now turn to the computation of the gradient of the in-
dividual joint log-likelihoods, liðgiÞ, with respect to the
random effect parameters, gi, using the approach of sensi-
tivity equations. Consider the differentiation done in Eq. 12.
Given values of h and gi, the quantities ij,Rij, andX can be
obtained by solving the model equations. However, we ad-
ditionally need to determine dij=dgik and dRij=dgik. Ex-


























The derivatives of h and Rij are readily obtained since
these expressions are given explicitly by the model for-
mulation. In contrast, the derivative of the state variables,
xij, are not directly available but can be computed from the
so called sensitivity equations. The sensitivity equations
are a set of differential equations which are derived by
differentiating the original system of differential equations
(and the corresponding initial conditions) with respect to



















The solution to the sensitivity equations can be used to
evaluate the derivatives in Eqs. 19 and 20, which in turn
are needed for the gradient of the individual joint log-
likelihoods. Importantly, these derivatives are also used for
computing the approximate Hessian, Eq. 14, appearing in
the approximate population log-likelihood.
In the unusual event that one or more of the random
effect parameters only appear in the observational model,
all sensitivities of the state variables with respect to those
parameters are trivially zero. Note also that the sensitivity
equations for all but trivial models involve the original
state variables, which means that the original system of
differential equations has to be solved simultaneously.
Thus, if there are q non-trivial sensitivities and n state
variables, the total number of differential equations that has
to be solved in order to be able to compute li and dli=dgi
for each individual is
nð1þ qÞ: ð22Þ
Gradient of the approximate population log-
likelihood with respect to the fixed effect parameters
We now derive the expression for the gradient of the ap-
proximate population log-likelihood, log LFðhÞ, with re-
spect to the parameter vector h. Differentiating log LF with
















Here it must be emphasized that all derivatives with respect
to components of the parameter vector h are taken after
replacing gi with g

i . This is critical since g

i is an implicit
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function of theta, gi ¼ gi ðhÞ. In other words, we have to
account for the fact that the gi maximizing the individual
joint log-likelihood changes as h changes.
To determine the total derivatives with respect to com-
ponents of the parameter vector h we will be needing the
following result. Consider a function v which may depend
directly on the parameters h and gi, and on the auxiliary
function w representing any indirect dependencies of these
parameters,
v ¼ vwðh; giÞ; h; gi

: ð24Þ
We furthermore introduce the function z to denote the
evaluation of v at gi ¼ gi ðhÞ,
z ¼ zwðh; gi ðhÞÞ; h; gi ðhÞ
 ¼ vjgi¼gi ðhÞ: ð25Þ
Separating the complete dependence of z on h into partial





















































































Thus, the total derivative with respect to h after insertion of
gi is equal to the sum of total derivatives with respect to h
and gi before insertion of g

i , where the second derivative is
multiplied with the sensitivity of the random effect opti-
mum with respect to the parameters h. It is straightforward
to see that this result holds also when differentiating func-
tions that only exhibit a subset of the possible direct and
indirect dependencies of Eq. 24, for instance functions with
just an indirect dependence on the two kind of parameters.
Applying the results from Eq. 26 to the first term within














However, since dli=dgi evaluated at g

i is zero by definition,












































Using asterisks to denote that gi has been replaced with g

i ,
we also get the following for the derivative of the second






















































































We now continue to expand the terms in Eqs. 28–32 con-
taining derivatives with respect to hm. The terms dX=dhm
and dX1kl =dhm are obtainable by straightforward differen-
tiation. Noting that the terms ij, ðdij=dgikÞ, Rij, and
ðdRij=dgikÞ, have indirect and/or direct dependence on h
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Here, dij=dgi was determined previously in Eq. 19, and
the derivative in the first term is given by
dij
dhm










The sensitivity of the random effect optimum with respect
to the fixed effect parameters, dgi =dh, must also be de-

























































































































where we after the third equality have used the results from
Eq. 19. The derivative of ðdRij=dgikÞ with respect to hm is
done in a highly similar way and is left to the reader as an
exercise.
In the above expressions, derivatives of h and Rij are
obtained by direct differentiation. The derivatives of the
state variables are determined by the previously derived
































































































As noted previously, all sensitivity equations must be
solved simultaneously with the original differential
equations for all but trivial models. However, since one or
more parameters in the vector h may not appear in the
differential equation part of the model (such as pa-
rameters appearing only in X), there may be sensitivities
which are trivially zero. If there are p non-trivial sensi-
tivities among the parameters in h, q non-trivial sensi-
tivities among the parameters in g, and n state variables,
the total number of differential equations that has to be
solved in order to be able to compute logLF and
d logLF=dh for each individual is
n

1þ q1þ pþ q=2: ð41Þ
Finally, we need to determine dgi =dh. At the the optimum










This equality holds for any h, and thus









Recognizing that dli=dgi fulfills the requirements of ap-





































The second order derivatives of the individual joint log-
likelihoods with respect to the random effect parameters
were previously derived in Eq. 13. In contrast to the first
order approximation of the Hessian used in the approximate
population log-likelihood, the second order derivatives of ij
and Rij are kept. These are obtained by differentiating
Eqs. 19 and 20 once more with respect to gi (not shown).
This in turn requires the second order sensitivity equations of
the state variables with respect to gi, which were previously
provided in Eq. 40. In addition to second order derivatives of
the individual joint log-likelihoods with respect to the ran-
dom effect parameters, Eq. 46 also requires the second order



























































Here, all terms have previously been introduced except
d2ij=dgikdhm and d
2Rij=dgikdhm, which are provided
within the derivation of Eq. 37 and through a correspond-
ing derivation involving Rij.
Better starting values for optimization of random
effect parameters
Computing the approximate population log-likelihood and
its gradient with respect to the parameters h requires the
determination of gi for every individual. The first time
log LF and its gradient are evaluated it is reasonable to
initiate the inner level optimizations for gi with gi ¼ 0.
However, in the subsequent steps of the optimization with
respect to h, better starting values for gi can be provided.
One way of choosing the starting values g0i for the opti-
mization of gi is to set them equal to the optimized value
from the last step of the outer optimization. If we for
simplicity of notation from now on suppress the index of gi
denoting the individual, i, and instead let the the index s
denote the step of the outer optimization with respect to h,
this can be expressed as g0sþ1 ¼ gs . This will be particularly
helpful as the optimization converges and the steps in h
become smaller. Using g from the evaluation of log LF as
starting value is also a good strategy when computing the
gradient of log LF by a finite difference approximation.
If the sensitivity approach is used for computing the
gradient of log LF , even better starting values of g can be
provided. This is accomplished by exploiting the fact that
the sensitivity dg=dh happens to be part of the gradient
calculation. By making a first order Taylor expansion of
the implicit function gðhÞ, we propose the following up-
date of the starting values of the random effect parameters
Fig. 1 Starting values for finding optimal random parameter values.
The hypothetical relationship between a parameter h and the optimal
value of a random effect parameter g is depicted by the solid curve,
and the optimal values of g for two consecutive h of the optimization,
hs and hsþ1, are shown as black points. The two approaches for
selecting starting values g0sþ1 are shown as dashed lines and gray
points, with the label (A) for using the previous value and (B) for
using the gradient based update
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g0sþ1 ¼ gs þ
dgs
dh
ðhsþ1  hsÞ: ð48Þ
The two approaches for choosing g0sþ1 are illustrated in
Fig. 1.
Results
Based on the theory presented in the previous section, we
propose an alternative implementation of the FOCE and
FOCEI methods for parameter estimation of NLME models
based on differential equations. The steps of this novel
approach are outlined in Algorithm 1. The crucial points
are the computation of gradients using sensitivity equa-
tions, for both the inner and outer problem, and the way
that starting values for the inner problem are determined.
The algorithm was evaluated using a two-compartment
model with a capacity-limited elimination. This is a mod-
erately complex pharmacokinetic model that requires the
numerical solution of differential equations. All details re-
garding the model, including model equations, parameters
used for simulating data, the starting values for the parameter
estimation, and the parameter estimates, can be found in the
‘‘Appendix 3’’ section. A short summary of the model is
shown in Table 1. Briefly, four versions of the model (M1-
M4) were used. In modelM1, some parameters were fixed to
the true values, hence excluded from the estimation. Three
random effect parameters were introduced but their
covariance matrix was limited to a diagonal matrix. Obser-
vations were modeled using a normally distributed additive
error. All parameters were estimated in modelM2, including
the full covariance matrix for the random effect parameters.
In model M3, an additional random effect parameter was
introduced and the full covariance matrix was extended ac-
cordingly. The observational model was also altered to in-
clude measurements from both compartments, and the error
in the measurements from the first compartments was mod-
eled with both an additive and proportional term. Model M4
is the same asM3 but for thismodel the parameter estimation
was performed with FOCEI instead of FOCE.
Improving gradient precision and accuracy
We compared our proposed method of computing the
gradient of the approximate population log-likelihood,
log LF , with respect to h to the more straightforward ap-
proach of finite difference approximation. Two versions of
the finite difference approximations were considered, a
forward difference and a central difference. To investigate
the precision and accuracy of these approximations, we
first determined the estimate of h for model M1. We then
computed all 6 elements of the gradient at this point in
parameter space using different values of the relative step
size, 10h. The details of the comparison are explained in
the methods section. In addition, we computed the gradient
using the approach based on sensitivity equations. A
comparison of the two approaches is shown in Fig. 2,
Algorithm 1 Parameter estimation algorithm
s := 0, θs := θstarting Initialize algorithm
for all individuals do
u := 0, ηus := 0
end for
repeat Solve the outer problem
for all individuals do
u := 0
repeat Solve the inner problem
Solve for x and the sensitivities dx/dη
Compute l and dl/dη
Update ηu+1s according to BFGS
u := u+ 1
until η∗s is obtained
end for
for all individuals do
Set η := η∗s
Solve for x and the sensitivities dx/dη, dx/dθ, d2x/dη2, and d2x/dηdθ
end for
Compute logLF and d logLF /dθ
Update θs+1 according to BFGS








s := s+ 1
until convergence of θ
198 J Pharmacokinet Pharmacodyn (2015) 42:191–209
123
where each row shows one element of the gradient at two
levels of magnification.
The left column of Fig. 2 shows a pattern that appears to
be consistent for all parameters; for large h, i.e. small step
sizes, the result of the finite difference approach is
dominated by numerical noise for both forward and central
differences. Thus, for this particular model, and for this
particular point in parameter space, the finite difference
approximations have low precision as h increases beyond
3. For small h, i.e. large step sizes, there is a trend of
severely decreased accuracy for the forward differences.
Looking at the values of the gradient from the approach of
sensitivity equations, it is clear that for h around 2 and
smaller, forward differences produces values of elements
of the gradient that are up to two orders of magnitude
larger, and with a wrong sign in four of six cases. The
behavior of the central difference approximation for small
and intermediate h is best viewed in the right column,
where the scales of the axis have been chosen differently.
For the three first elements of the gradient, namely the
derivatives of log LF with respect to Vmax, V1, and Km, the
central difference approximation appears to be accurate but,
on the scale of the size of the gradient computed according to
the sensitivity equation approach, the limits in precision are
visible. For the derivatives with respect to the the parameters
of X, x11, x22, and x33, there are obvious issues with both
accuracy and precision of the approximation, producing
derivatives that are both of wrong size and sign. The fact that
the approximation starts to deviate systematically for h less
than 2 indicates that in these parameter directions, and on this
scale, an expansion of the approximate log-likelihood
function has a significant contribution of third order terms
and higher, causing a bias in the approximation of the gra-
dient using central differences.
The approach of determining the gradient using sensi-
tivity equations is also subject to numerical errors. By re-
peated evaluation of the gradient using randomized values
for the starting values of the inner optimization problem,
we determined the relative standard error. For all 6
parameter directions of the gradients, the relative standard
errors were between 0.1 and 1 %. Thus, these numerical
errors are so small that they would not even be visible on
the scales of Fig. 2.
Improving computational time
We investigated the improved computational times result-
ing from replacing finite difference approximations of the
gradients in the inner and outer problem with gradients
computed using sensitivity equations, and from using better
starting values for the inner problems. The contribution
from each of these three steps, as well as their accumula-
tive effect, are shown in Fig. 3.
For the first step of improvement, using gradients based
on sensitivity equations for the inner problem, computa-
tional times for models M1 and M2 (with 3 random effect
parameters) decreased to almost a third compared to the
approximation using forward differences, and to a fifth
compared to central differences. The ratio of these two
relative decreases is reasonable considering that the for-
ward difference approximation requires 4 function
evaluations and the central difference requires 7 evalua-
tions. Model M3 and M4 contain one additional random
effect parameter and the gains in speed were slightly larger
compared to both variants of the finite difference
approximation.
Replacing the finite difference approximation of the
gradient in the outer problem with the approach based on
sensitivity equations results in further improvement of
computational times. As the number of parameters in the
outer optimization problem increase from 6 to 18 for the
models M1 to M3, the reduction in computational times
improves from 29 to 14 % when compared to forward
differences, and from 16 to 7 % compared to central dif-
ferences. Although model M4 is identical to M3, the re-
duction in computational times are slightly less for this
model. This is because M4 uses FOCEI for estimating
parameters, which compared to FOCE requires more time
Table 1 Overview of benchmark models showing the method used,
the numbers of different types of parameters, and the total number of
ordinary differential equations (ODEs) per individual for the inner
and outer problem (including the number of sensitivity equations
according to Eqs. 22 and 41)
Model M1 M2 M3 M4
Method FOCE FOCE FOCE FOCEI
Total number of fixed effect parameters (h) 6 12 18 18
Parameters in the ODE model 3 5 5 5
Parameters in the observational model 0 1 3 3
Parameters in the random effect covariance matrix 3 6 10 10
Number of random effect parameters (g) 3 3 4 4
ODEs per individual, inner problem 8 8 10 10
ODEs per individual, outer problem 44 60 80 80
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for putting together the more complex gradient expressions
once the sensitivity equations have been solved. Again it is
reasonable to expect a nearly doubled factor of decrease
when comparing central and forward finite differences
since the former need almost twice as many function
evaluations.
The final step of improvement is only applicable when
gradients for both the inner and outer problem are com-
puted using the approach based on sensitivity equations.
Thus, the distinction between forward and central differ-
ences is no longer of importance. The decrease in com-
putational times were around 70 % for models M1 to M3,
and somewhat less for model M4, which again benefits less
due to its larger overhead of having to compute all inter-
action terms.
The accumulated effect of all the steps range from a
decrease in computational times to 7 % for the least
complex model when comparing to forward differences, to
the substantial decrease to 1 % for the most complex model
when comparing to central differences.
Discussion
This article has demonstrated a novel approach to the
computation of gradients needed for the FOCE and FOCEI
approximation of the population likelihood encountered in
NLME modeling. We have derived the analytic expres-
sions for the gradients of both the individual and popula-
tion log-likelihoods as well as the so called sensitivity
equations, whose solution is a necessity for evaluating the
gradient expressions.
Using sensitivity equations to compute the gradient for
the inner problem is quite straightforward. As we under-
stand it, approaches along these lines are in fact used for
the inner problem, at least to some extent, in softwares such
as NONMEM and Phoenix NLME. For the approximate
population log-likelihood on the other hand, the sensitivity
approach to gradient computation is complicated by the
fact that this function depends on the nested optimization
of the individual joint log-likelihoods. In this work we
have, to the best of our knowledge, for the first time
demonstrated how sensitivity equations can be used for
computing the gradient of the FOCE and FOCEI ap-
proximations to the population log-likelihood. A key step
to obtain this gradient involves the derivative of the opti-
mal random effect parameters with respect to the fixed
effect parameters. It was shown that this derivative could
be determined given second order sensitivity equations.
Abandoning the finite difference approximation of gra-
dients in favor of the approach of sensitivity equations
were shown to have two advantages; gradients could be
computed with a higher precision and computational times
were substantially reduced. Though, implementation of the
presented method is more challenging compared to finite
difference FOCE/FOCEI, and the limitations of the
Laplacian approximation are still present.
Fig. 2 Precision and accuracy of the approximate population log-
likelihood gradient. Each row displays one element of the gradient,
and the left and right columns show two different levels of
magnification, respectively. Evaluations of the derivatives of logLF
using forward and central differences with different relative step sizes
are shown as blue and red dots, respectively. A single evaluation of
the derivatives using the approach based on sensitivity equations is
indicated by a black line, and the value zero is shown as a dashed line
for comparison
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Increased precision and accuracy of gradients
The optimization of the approximate population log-likeli-
hood log LF with respect to h would typically be performed
with a quasi-Newton method. A straightforward approach
to obtaining the gradient needed for such methods is to
compute it from a finite difference approximation. How-
ever, the finite difference approach may result in issues with
both precision and accuracy of the gradient. We demon-
strated this for the computation of the gradient in the outer
problem, evaluated close to the optimum of log LF .
Although the use of central differences with an appropriate
step length could avoid the worst problems, precision and
accuracy were still inferior compared to the approach based
on sensitivity equations. The potential limitations of com-
bining NLME models based on differential equations with
likelihood optimization using gradients computed by finite
differences have previously been recognized [3]. The issues
with the finite difference approximation depend both on
numerical limitations and on the approximation itself. First
of all, evaluation of log LF can only be done to a certain
precision. This is especially evident for models based on
differential equations, whose solution involves adaptive
schemes for numerical integration. In addition to the nu-
merical precision of functions like log, which is high, the
precision of log LF depends on the precision of the solutions
to the differential equations, and the precision of computing
derivatives with respect to g. The precision of logLF also
has a strong dependence on the precision of g, which in
turn again depends on the solutions of differential equations
and, if the inner level optimization problem is performed
using a gradient-based method, depends on computing
derivatives of the individual joint log-likelihoods with re-
spect to g. Secondly, taking finite differences of log LF will
amplify numerical errors, resulting in increasingly poor
precision of the gradient as the step size is decreased. On the
other hand, taking too long steps will decrease the accuracy
of the approximation due to the increasing impact of higher
order terms in an expansion of log LF (forward differences
is only exact up to first order terms, and central differences
is only exact up to second order terms). Even if it for a given
model in some cases would be possible to customize the
step length for the finite difference approximation (which
typically would be different in each separate parameter
direction) using an analysis like the one performed here, it
would be infeasible in practice since such an investigation
may take longer time than solving the parameter estimation
problem itself. Adding further to the problem, the choice of
a suitable step size will most certain be different depending
on the point in parameter space, thus constantly requiring a
reevaluation of the step size.
There are several advantages of being able to compute
gradients with an improved precision and accuracy
(i) Parameter estimates can be computed with higher pre-
cision, or alternatively, the same precision can be obtained
but with shorter run times since we may afford to reduce
the precision of the inner problem while still maintaining a
similar precision in the outer problem [11]. (ii) Premature
termination and convergence problems of the parameter
estimation algorithm can be avoided or at least reduced [8,
24]. (iii) May enable the calculation of standard errors of
the parameter estimates in cases where this was not pos-
sible due to the numerical issues of the finite difference
approach [7]. However, we want to point out that for many
points in the parameter space the limited precision and
accuracy of the finite difference approach may not be
crucial for the progression of the optimization as long as
the approximation of the gradient results in a true ascent
direction of the function being maximized.
Decreased computational times
The relative decrease in computational times were inves-
tigated for the successive application of three specific steps
toward improvement, namely (i) Gradients based on sen-
sitivity equations in the inner problem, (ii) Gradients based
on sensitivity equations in the outer problem, and (iii)
Better starting values for the inner problem. In all cases of
applying the two first steps, we found that the decrease in
computational times were substantially larger when com-
paring to central differences instead of forward differences.
This was anticipated since central differences requires al-
most twice as many function evaluations as forward dif-
ferences. Moreover, for both the inner and outer levels of
optimization, the gains in computational times tended to be
larger for models with higher number of parameters. For
instance, the run time improvements of providing gradients
from sensitivity equations in the outer problem were more
than doubled for model M3 with 18 parameters compared
to model M1 with 6 parameters. It was also observed that
the improvement factor in the outer optimization was
slightly lower for FOCEI compared to FOCE. Although the
number of ODEs to be solved in both the inner and outer
problem is the same, this was expected considering that the
FOCEI method is based on more extensive expressions for
both the likelihood and its gradient.
There are two main reasons why the approaches based
on sensitivity equations should be faster. First of all, the
right hand side of the sensitivity equations has lots of
common subexpressions both with other sensitivity equa-
tions and with the original system of differential equations.
Thus, the cost of evaluating the right hand side for the
combined system of the original differential equations and
the sensitivity equations can be surprisingly small. Fur-
thermore, since the sensitivity equations are linear in the
sensitivity state variables, there is typically little extra
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effort needed in the adaptive time stepping of the differ-
ential equations solver for accommodating these additional
equations. For the inner problem this means that it is faster
to solve the combined system, yielding in total nð1þ qÞ
differential equations, rather than having to solve the n
original differential equations 1þ q times, which would
have been the case using forward finite differences. Se-
condly, the use of sensitivity equations in the outer level
optimization avoids the repeated need of having to solve
the inner problems for perturbed values of the outer pa-
rameters. The exact improvement made at this step de-
pends on several factors of which perhaps the most
important one is the desired precision (and hence the
number of iterations required) of the inner optimizations
needed for every parameter perturbation of a finite differ-
ence approximation (had this alternative been used
instead).
We furthermore note that the computation of gradients
based on sensitivity equations is highly amenable to par-
allelization, something which may be exploited to speed up
computations considerably. The potential gains of doing
this are expected to be similar to those of parallelizing the
computation of the population log-likelihood itself [11].
In addition to the reduced computational times coming
from the two steps of improved gradient computations, a
third level of speed up was obtained by choosing more
informed starting values for the inner problem. Although
this improvement was not as substantial as the others, the
gains from this step may be quite dependent on the starting
values of the outer optimization problem. As the outer level
optimization converges, the steps in h become successively
smaller, which in turn means that the linear approximation
of gðhÞ becomes better. Thus, the overall improvement in
computational time will depend on how much of the op-
timization that was spent in these ‘‘later stages’’ of con-
vergence. This means that it is likely that the relative
improvement will be larger if the optimization had been
started closer to the optimum.
Setting the results of Fig. 3 in relation to commercial
softwares for NLME parameter estimation, we would like
to comment on a mixed analytical/finite difference ap-
proach to the differentiation of the FOCE likelihood with
respect to the parameters of the random effect covariance
matrix X, which is used as default by NONMEM (when
the SLOW option is not selected). Since these parameters
do not normally directly influence neither the residuals, nor
the residual covariance matrix, their part of the likelihood
gradient is less complicated compared to other parameters.
As shown by the theory in this paper, their part of the
gradient may be computed using only second order g
sensitivities (Eq. 40), not requiring first order h or second
order mixed sensitivities (Eqs. 38 and 39, respectively).
Although NONMEM FOCE does not use second order g
sensitivities, it still utilizes this technique by performing a
central finite difference evaluation on the first order g
sensitivities. While this is slower than performing com-
pletely analytical second derivatives, along with some
erosion of precision, it is certainly faster than the SLOW
FOCE method, which must perform the inner problem re-
optimizations at each outer level perturbation of the X-
parameters. The derivatives of the likelihood with respect
to the remaining parameters are still obtained from finite
differences.
The degree of improvement of speed for the S-S ap-
proach compared to an approach that is mixing finite dif-
ferences and analytical methods at the outer level, i.e, an S-
F/S approach, may therefore be less substantial than what
can be achieved for going from S-F to S-S. Under the
realistic assumption that all perturbed evaluations of log LF
are equally costly, and further assuming that the X-part of
the gradient can be obtained at a computationally in-
significant cost (ignoring the relatively few extra evalua-
tions needed for the central finite difference of the first
order g sensitivities), the reference time of 100 % for going
from forward differences S-F to S-S in Fig. 3 would
change to ðð1þ Ph  PXÞ=ð1þ PhÞÞ100 % if instead going
from S-F/S to S-S, where Ph is the total number of pa-
rameters and PX is the number of X-parameters. The ref-
erence time for going from central differences S-F to S-S
would for S-F/S to S-S similarly change to
ðð1þ 2Ph  2PXÞ=ð1þ 2PhÞÞ100 %. For model M1 this
would mean that the improvements to 29 and 16, for for-
ward and central differences, respectively, should be
compared to the S-F/S references of 57 and 54, rather than
to 100, and for model M3 the improvements to 14 and 7
should be compared to 47 and 46. In general, one would
expect the advantage of the S-S approach to decrease as the
fraction of X-parameters with respect to the total number
of parameters increases, e.g., for problems with many
random effect parameters when estimating the full random
effect covariance matrix. It must however be emphasized
that this is a mixed analytical/finite difference approach,
and may as such have lower precision and accuracy com-
pared to the S-S approach. Moreover, the remaining part of
the gradient will still be completely derived from finite
differences, and is expected to have the same comparable
quality to the S-S approach as demonstrated in the results
section.
Extending the line of thought, one could also consider a
hybrid between the above S-F/S approach and the S-S
approach, where the derivatives of log LF with respect to
the X-parameters are computed according to the exact
approach presented in this work but where the deriva-
tives for the remaining parameters of the outer level
problem are obtained from a finite difference approach.
This would indeed require the second order sensitivity
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equations with respect to g, but not the first order h or
the mixed second order sensitivity equations. The accu-
racy and precision would still be lower for the part of
the gradient obtained from finite differences but the
elements corresponding to the parameters of X would be
of the same quality as the S-S approach, i.e., without
approximations.
Challenges and limitations
Moving from a convenient proof-of-concept environment
such as Mathematica, in which the proposed method cur-
rently is implemented, to a more stand-alone environment
of a commercial software may present various challenges.
One of the most obvious challenges is the integration of
Fig. 3 Comparison of relative
estimation times. The relative
computation times expressed in
percentage are shown for going
from one scheme for obtaining
gradients to another. Results are
shown for the model variants
M1-M4, using either a forward
or central implementation of the
finite difference approach. F-F
denotes the use of finite
differences for both the inner
and outer problem, S-F the use
of gradients based on sensitivity
equations for the inner problem,
S-S the use of gradients based
on sensitivity equations for both
inner and outer problems, and S-
S-g denotes the additional
implementation of the better
starting values for the inner
problem
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functionality for performing symbolic differentiation. This
is essential since the sensitivity equations, i.e., the differ-
ential equations in Eqs. 21, 38, 39, and 40, are model
specific and have to be derived for every new model, in
order to apply the results of this paper. It also applies to the
derivatives of h, Rij, and X, which too are model specific.
Since differential equation models may be quite complex,
and because second order derivatives are needed, it is not
realistic to perform these derivations manually, and a tool
that can perform symbolic differentiation will be required.
To this end, one may consider to look at free symbolic
packages such a SymPy [23]. The use of tools for symbolic
analysis may furthermore be crucial to exploit the existence
of common subexpressions, e.g., in the right hand sides of
the sensitivity equations.
An alternative approach, which does not require sym-
bolic differentiation, would be to use so called automatic
differentiation (AD) [19]. The idea of AD is that every
mathematical function that can be written as a computer
program can be differentiated by applying the chain rule of
differentiation, leading to the differentiation of every ele-
mentary operation of that computer program. Even though
AD in principle could be applied directly to the ap-
proximate population likelihood, whose gradient we wish
to compute, this would in practice be infeasible as this
function is based on the execution of both optimization
routines and adaptive numerical integration of differential
equations. If used, AD would therefore not be applied to
the population likelihood, but to the right hand sides of the
model differential equations, and to the other model objects
requiring differentiation. The parameter estimation would
thus still proceed according to the steps laid out in Algo-
rithm 1, but with symbolic differentiation replaced with
AD. Following such an approach, the precision and accu-
racy of the gradients are not expected to differ, but it would
have to be investigated how AD performs in terms of
computational times. With a so called reverse mode AD it
may actually be possible to improve run times even further
compared to the current results.
Even if tools for differentiation can be provided for a
stand-alone implementation, estimation methods which in-
volve the direct differentiation of model state variables, etc.,
may experience limitations when considering other types of
mathematical formalisms, such as models based on
stochastic differential equations or hidden Markov models,
since the required derivatives may be challenging to obtain.
The method of computing gradients based on finite differ-
ences, on the other hand, do not care about the details of how
a model is evaluated and has no limitations in this sense.
Finally, it should also be mentioned that although the
approach for gradient computations presented here may
improve the performance of FOCE and FOCEI, the
fundamental limitations of the Laplacian approximation as
such still remains. Being only an approximation to the
population likelihood, this class of methods do not guar-
antee the desirable statistical properties of a true maximum
likelihood estimate. In this respect the new generation of
estimation methods which are based on Monte Carlo ex-
pectation maximization methods, such as stochastic ap-
proximation expectation maximization and importance
sampling, are superior to the classical ones since the pa-
rameter estimates and their confidence intervals, etc., are
not biased by likelihood approximations. However, FOCE
and FOCEI will likely be important complementary
methods for a long time still, and improving their effi-
ciency is therefore nonetheless relevant.
Possible extensions
The approach of computing gradients using sensitivity
equations presented here could bemodified for other variants
of the population likelihood based on the Laplacian ap-
proximation. For instance, with some alterations it could be
applied to the first order (FO) approximation of the popula-
tion likelihood. Since the FO method does not rely on con-
ditioning with respect to the optimal random effect
parameters, the use of an approach based on sensitivity
equations would be less complicated but at the same time
also less rewarding. Gradients based on the approach of
sensitivity equations could with some adjustments also be
derived for the Laplacemethod. This would however require
third order sensitivity equations butmay beworthwhile since
the potential gains should be at least as substantial as for
FOCE and FOCEI. Because the theory presented in this ar-
ticle is derived for the FOCEI approximation, it accounts for
the dependence of residual errors on the random effect pa-
rameters. This means that the gradient expressions stated
here are suitable for prediction error-type NLME models,
including models based on stochastic differential equations
(see for instance [6, 14, 18]), since these typically display an
interaction between residuals and random effects. The first
step towards this end has in fact already been taken through
the successful application of sensitivity equations for com-
puting gradients in stochastic differential equationmodels on
the single-subject level [16]. Furthermore, gradient com-
putations based on sensitivity equationsmay be useful for the
problem of optimal experimental design [1, 17].
Conclusions
The presented approach of computing gradients for both
the individual- and population-level log-likelihoods of the
FOCE and FOCEI approximations leads to more robust
gradients and decreased computational times. We therefore
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suggest that future implementations of these conditional
estimation methods should include the approach based on
sensitivity equations for computing the gradients. We ea-
gerly await the further development of the proposed ap-
proach from the prototyped version used in the present
study to its implementation in publicly or commercially
available software packages.
Methods
The NLME parameter estimation algorithm investigated in
this study was implemented in Mathematica 9. An execu-
table version of the code, and the data sets used within this
study, may be received from the authors upon request.
Comparison of performance
The performance of a computer program for parameter
estimation in NLME models depends on several factors,
such as the particular NLME model, the experimental data,
how the estimation problem is formulated and possibly
approximated, the choice and settings of the optimization
method (including sub-methods such as line-searches, etc.),
starting values of parameters, the differential equation
solver used, the design of convergence criteria, etc. This
paper is investigating the advantages of providing gradients
by means of sensitivity equations for the FOCE or FOCEI
approximation of the population likelihood. However, this
paper is not claiming to address all the other factors that
will impact on the parameter estimation. Comparing mea-
sures such as absolute run-times of our implementation
with commercial software like NONMEM may therefore
be misleading with respect to the advantages of gradient
calculations. To avoid this the comparison is designed to
look only at the improvements made by abandoning the
finite difference approximation in our own implementation.
Comparison of precision and accuracy
The comparison of precision and accuracy was performed
in the following way. At the optimal values of h (found
from the comparison of computational times), the elements
of the gradient of the approximate log-likelihood function
were approximated with finite differences, using a relative

















For these function evaluations, the inner problemwas solved
to a precision of 4 digits (using the gradients from the ap-
proach of sensitivity equations). Furthermore, for forward
differences the value of log LF was recalculated for every h
using randomized starting values for the inner problems.
Thiswas done to avoid correlations between differenceswith
different step size that may otherwise have resulted from a
single realization of the numerical error of log LF .
The approach of determining gradients using sensitivity
equations does not involve any approximations, and is
therefor expected to be correct on average. Its precision
was assessed by computing the gradient 500 times using
randomized starting values for the inner problems. For
these gradient evaluations, the inner problem was solved to
a precision of 4 digits.
Comparison of computational times
The comparison of computational times was done in the
following way. Both the inner and outer problem were
solved using gradients based on sensitivity equations, as
outlined in the theory section. The inner problem was
solved to a precision of 4 digits, and the outer to a precision
of 3 digits. The comparison to finite differences was done
by simultaneously clocking the time of computing gradi-
ents by a finite difference approximation but proceeding
with the optimizations according to values of the gradient
from the sensitivity approach. The reason for doing this is
that the number of iterations, and the properties of every
iteration (such as stiffness of the model equation with that
certain set of parameters), for solving both the inner and
outer problem might be affected by the choice of method
for computing the gradients. Even small numerical differ-
ences in the results of the two methods may cause the paths
taken in the parameter space to diverge substantially over
the course of the optimizations, potentially making the
comparison unfair. In this way we isolate the comparison to
the actual computational times for the different methods of
obtaining the gradients. Since the methods based on sen-
sitivity equations were shown to have a higher precision in
the evaluation of gradients, there may be additional gains
in computational times to be made from traversing the
parameter space based on more exact gradients. However,
quantifying this type of contribution may require averaging
over a large number of models and parameter starting
values and was not considered. Thus, our implementation
of the comparison focuses on the direct improvements in
computational times and will therefore be a conservative
measure of the gains in speed.
To make a fair implementation of timing the finite dif-
ferences approach the following starting values of the
random effect parameters for the inner problem were used.
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When evaluating the approximate population log-likeli-
hood at the unperturbed parameter values of the outer
problem, the starting values for the parameters of the inner
problem were set to the optimum from the previous outer
evaluation, i.e., according to approach A in Fig. 1. For
evaluating the approximate population log-likelihood at the
perturbed parameter values of the outer problem, the
starting values for the parameters of the inner problem
were set to the optimum obtained for the unperturbed outer
problem parameters. The relative size of each perturbation
of the parameters in h was 102.
Compared to the finite difference approaches, using
sensitivity equations had an overhead of evaluating the
quite substantial mathematical expressions for the gradi-
ents once the differential equations are integrated, some-
thing which was carefully included in the comparison of
computational times.
Optimization algorithm
Both the inner and outer optimization problems were
solved using the BFGS method [20].
Derivation of sensitivity equations
Given an NLME differential equation model, the corre-
sponding sensitivity equations were derived by symbolic
differentiation in Mathematica.
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Appendix 1: Matrix calculus












The derivatives of vectors and matrices by scalars are de-




























































































































The derivative of a quadratic form is obtained in the fol-
lowing way. Let y ¼ bTAb, where A is a square matrix and






















The derivative of an inverse matrix is found by noting that
























The derivative of the logarithm of the determinant of a
covariance matrix is given by the following expression. If
A is a real-valued, symmetric, positive-definite matrix, then
d
dx





This can be seen by first writing A as A ¼ QKQ1, where




log jAj ¼ d
dx





























































Appendix 2: Hessian approximation
For an appropriate model, it holds that







where the expected values are taken with respect to data,
which here are considered to be random variables whose
values have not yet been realized. Based on these equa-
tions, the Hessian in Eq. 13 can be simplified to various
degrees by approximating its different terms with their
expected values. A minimal simplification for eliminating






























































where we are making use of the fact that the trace of a
scalar is just the scalar, the order of the expectation and
trace operators can be shifted, and the cyclic property of
the trace operator. This simplification is used in the present
study.
Further simplifications of Eq. 13 may be performed by






































































which is the variant used in NONMEM [2].
Appendix 3: Benchmark models and data
The equations for the two-compartment pharmacokinetic
model are










¼ Cld ðc1ðtÞ  c2ðtÞÞ
c1ð0Þ ¼ c2ð0Þ ¼ 0; ð71Þ
where uðtÞ is an input function, which was used to model a
constant infusion with the rate 0.67 per minute during the
first 30 minutes followed by another 30 minutes of wash-
out. For models M1 and M2, the scalar-valued observation





For models M3 and M4, the vector-valued observation
model was defined by yt ¼ ðc1ðtÞ; c2ðtÞÞ þ et, where





In models M1 and M2, the three parameters Vmax, Km, and
V1, were defined to be log-normally distributed on the
population level. This was accomplished by multiplying
them with expðg1Þ, expðg2Þ, and expðg3Þ, respectively,
where g ¼ ðg1; g2; g3Þ is normally distributed with zero
mean. In the first variant of this model, M1, the covariance










and in the second variant, M2, the full matrix is estimated
using the parameterization
X ¼
x211 þ x212 þ x213 x12x22 þ x13x23 x13x33







to ensure positive definiteness. In models M3 and M4, an
additional random effect parameter was in the same way
introduced for the parameter Cld. A similarly defined full
matrix for 4 random effect parameters was used for models
M3 and M4.
The parameter values used for simulating data are
shown in Table 2, together with information of which pa-
rameters are being estimated in the four model variants,
and what the starting values of the estimation were. One
data set consisting of 10 simulated individuals was used for
models M1 and M2. Here, the values of c1 were collected
at the time points t ¼ 10; 15; 20; . . .; 60. For models M3
and M4, another data set consisting of 20 simulated
Table 2 Parameter values used for simulating data (D), starting values for estimation (S), and parameter estimates (E) for the different models
Parameter D S, M1 S, M2 S, M3/M4 E, M1 E, M2 E, M3 E, M4
Vmax 0.5 0.2 0.2 0.2 0.424 0.419 0.473 0.473
Km 4 3 3 3 3.91 2.53 4.37 4.37
Cld 0.01 – 0.01 0.01 – 0.00976 0.00813 0.00813
V1 0.3 0.1 0.1 0.1 0.288 0.285 0.321 0.321













p   0:707 - -
ﬃﬃﬃﬃﬃﬃ
0:1




p  0:707 1 1 1 0.616 0.553 0.559 0.560
x12 0 – 0 0 – -0.0518 -0.123 -0.123
x13 0 – 0 0 – 0.439 -0.138 -0.138
x14 0




p  0:707 1 1 1 0.772 0.575 0.533 0.533
x23 0 – 0 0 – 0.485 0.0174 0.0174
x24 0




p  0:707 1 1 1 0.994 1.39 0.776 0.776
x34 0




p   0:707 - - 1 - - 0.870 0.870
Parameters which were not estimated are indicated with a dash. The * indicate that a parameter is only used in models M3 and M4
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individuals was used, where the values of c1 and c2 were
collected at the time points t ¼ 10; 15; 20; . . .; 60.
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